Join to View Full Profile
600 Highland AveMadison, WI 53792
Phone+1 608-915-0100
Dr. Serritella is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins University School of MedicineClass of 2017
Certifications & Licensure
IL State Medical License 2017 - 2026
WI State Medical License 2024 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsA Phase I/II Trial of Sapanisertib in Advanced Anaplastic and Radioiodine Refractory Differentiated Thyroid Carcinoma.Kartik Sehgal, Anthony Serritella, Mofei Liu, Anne ONeill, Chaitali Nangia
The Journal of Clinical Endocrinology and Metabolism. 2025-04-22 - Correction to: Metastatic Hormone-Sensitive Prostate Cancer in the Era of Doublet and Triplet Therapy.Anthony V Serritella, Maha Hussain
Current Treatment Options in Oncology. 2025-02-01 - 4 citationsGermline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2).Andrew J Armstrong, Amy Taylor, Michael C Haffner, Wassim Abida, Alan H Bryce
Prostate Cancer and Prostatic Diseases. 2024-10-01
Press Mentions
No Clinically Meaningful Difference in Survival Between Nivolumab plus Ipilimumab and Nivolumab Alone in Advanced Cancers Other Than MelanomaSeptember 21st, 2023- Combination Immunotherapy Shows No Additional Benefit for Most Advanced CancersSeptember 22nd, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
